Target intelligence / Profile preview

CYCS pseudogene 56 (CYCSP56)

Target
CYCSP56
Molecular classification
Pseudogene, processed pseudogene, non-coding DNA
01

Overview

CYCS pseudogene 56 is a processed pseudogene related to the cytochrome c gene (CYCS), an essential protein in electron transport and apoptosis. Processed pseudogenes like CYCSP56 arise from the reverse transcription of mRNA and reintegration into the genome, lacking introns and regulatory elements of the original gene[3][6][1]. CYCSP56 does not produce a functional protein, lacks gene expression, and has been confirmed experimentally to be non-functional[1][2][5]. It holds no therapeutic, diagnostic, or molecular target significance, but may be relevant as a technical consideration to avoid confusion with the functional gene in genetic assays[4][11]. CYCSP56 is not a receptor, enzyme, or any other molecular target category relevant for drug intervention—its designation as a "target" is incorrect. The presence of multiple CYCS pseudogenes in the human genome is well-documented; CYCSP56 is part of this family and is cataloged as non-expressed and non-functional[1][2][5]. Care should be taken to distinguish between CYCSP56 and the functional CYCS gene when designing experiments or interpreting molecular diagnostic data[4][11].

Other names
CYCSP56cytochrome c pseudogene 56
02

Mechanism of action

None

03

Biological functions

None (pseudogenes do not encode a functional protein)
04

Disease associations

None (no established direct role in disease; pseudogenes can sometimes interfere with genetic diagnostics)
05

Safety considerations

Potential for confusion in molecular diagnostics or genetic sequencingpseudogenes can complicate accurate measurement of functional gene variation due to sequence similarity
06

Interacting drugs

None
07

Biomarkers

None

Beyond the preview

Go deeper on CYCS pseudogene 56 (CYCSP56).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CYCS pseudogene 56 (CYCSP56).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call